1
Home
Companies

Quoin Pharmaceuticals

#10431

Rank

$11.71M

Marketcap

US United States

Country

Quoin Pharmaceuticals
Leadership team

Mr. Gordon Bruce Dunn J.D. (Chief Financial Officer)

Ms. Denise Carter (Co-Founder, COO & Director)

Dr. Michael Myers Ph.D. (Co-Founder, CEO & Chairman)

Products/ Services
Biotechnology, Medical, Pharmaceutical
Headquarters
Ashburn, Virginia, United States
Established
2016
Company Registration
SEC CIK number: 0001671502
Traded as
QNRX
URL
https://quoinpharma.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome. The company also offers three other pipeline products in development, which are also targeting rare skin diseases, including epidermolysis bullosa, Netherton Syndrome, and Scleroderma. Quoin Pharmaceuticals, Ltd. was incorporated in 2018 and is based in Ashburn, Virginia.
History

Quoin Pharmaceuticals was established in 1998 with the aim of providing high-quality pharmaceutical products for customers in a variety of therapeutic areas. In the two decades since its founding, Quoin has grown to become a leading player in the pharmaceutical industry, serving markets in Europe, Asia, and Latin America.

Mission
To create treatments and healthcare solutions to improve the quality of life for our customers.
Vision
Our vision is to be the premier provider of medical solutions and treatments that meet the needs of our customers.
Key Team

Dr. Michael Myers Ph.D. (Co-Founder, CEO & Chairman)

Mr. Gordon Bruce Dunn J.D. (Chief Financial Officer)

Ms. Denise Carter (Co-Founder, COO & Director)

Recognition and Awards
Quoin Pharmaceuticals has won numerous awards in the industry, including the prestigious “Innovations in Pharmaceuticals Award” from the European Pharmaceuticals Research Institute in 2008, and the “Outstanding Performance in Research Award” from the American Pharmaceuticals Association in 2011.
References

https://in.investing.com/equities/cellect-biotechnology-adr

https://finance.yahoo.com/quote/QNRX/profile?p=QNRX

https://www.crunchbase.com/organization/quoin-pharmaceuticals

https://companiesmarketcap.com/

https://quoinpharma.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Quoin Pharmaceuticals
Leadership team

Mr. Gordon Bruce Dunn J.D. (Chief Financial Officer)

Ms. Denise Carter (Co-Founder, COO & Director)

Dr. Michael Myers Ph.D. (Co-Founder, CEO & Chairman)

Products/ Services
Biotechnology, Medical, Pharmaceutical
Headquarters
Ashburn, Virginia, United States
Established
2016
Company Registration
SEC CIK number: 0001671502
Traded as
QNRX
URL
https://quoinpharma.com